Novo Nordisk filed a New Drug Application for the CagriSema combination (cagrilintide 2.4 mg + semaglutide 2.4 mg) in December 2025, with an FDA decision anticipated in late 2026
Talk to your doctor first to make sure it is safe for you and will not cause any problems
As subjects were included when either treatment combination was initiated, any previous use of metformin, GLP-1 RA or DPP-4is alone or in combination with any other glucose-lowering drug was allowed
You need them for energy and metabolism
Each vial ships with a Certificate of Analysis documenting: Identity Verification HPLC and Mass Spectrometry Purity Analysis HPLC quantification Endotoxin Screening LAL assay Sterility Microbial contamination screening Heavy Metals Lead, mercury, cadmium analysis Physical Inspection Color, clarity, appearance Traceability Batch numbers, test dates, storage specs Important Notice This product is intended for laboratory research use only
I typically suggest a facelift and necklift with fat grafting, says Dr